SUSPECTED PRODUCT QUALITY ISSUE

This adverse event was reported 1833 times

These drugs are most commonly taken by patients reporting SUSPECTED PRODUCT QUALITY ISSUE:

# Drug Count
0 ERGOCALCIFEROL 65
1 ESTRADIOL 50
2 ONABOTULINUMTOXINA 41
3 CLONAZEPAM 37
4 LEVOTHYROXINE SODIUM 37
5 METFORMIN 37
6 AFLIBERCEPT 33
7 AMLODIPINE 33
8 ESTRADIOL GEL 0.1% 32
9 ESTRADIOL TRANSDERMAL 32
See all common drugs associated with SUSPECTED PRODUCT QUALITY ISSUE

SUSPECTED PRODUCT QUALITY ISSUE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10% 20 0.0525
1 CETRORELIX ACETATE 11 0.0174
2 ESTRADIOL ACETATE 10 0.0128
3 MOMETASONE FUROATE MONOHYDRATE 5 0.0098
4 ROPIVACAINE HYDROCHLORIDE 20 0.0082
5 IOPROMIDE 26 0.0062
6 ESTRADIOL AND LEVONORGESTREL 7 0.0034
7 TUBERCULIN PURIFIED PROTEIN DERIVATIVE 5 0.0027
8 INCOBOTULINUMTOXINA 13 0.0022
9 ERGOCALCIFEROL 65 0.0022
See all drugs enriched for association with SUSPECTED PRODUCT QUALITY ISSUE

SUSPECTED PRODUCT QUALITY ISSUE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Skin Test Antigen [EPC] 5 0.0027
1 Guanylate Cyclase-C Agonist [EPC] 5 0.0024
2 Provitamin D2 Compound [EPC] 65 0.0022
3 Gadolinium-based Contrast Agent [EPC] 8 0.0016
4 Human Immunoglobulin G [EPC] 33 0.0016
5 Radiographic Contrast Agent [EPC] 27 0.0010
6 Ectoparasiticide [EPC] 4 0.0010
7 Phenylalanine Metabolizing Enzyme [EPC] 8 0.0009
8 Progesterone [EPC] 21 0.0009
9 General Anesthetic [EPC] 30 0.0007
See all drug classes enriched for association with SUSPECTED PRODUCT QUALITY ISSUE